It is a chemicals public limited company based in Hyderabad, Telangana, India, established in 2004.
2004 | Hyderabad, Telangana, India | ActiveAmbit Drugs Limited, a active public limited company, was established on 13 September 2004 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239TG2004PLC044152. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Regulapati Srinivas Rao (Director), Chittireddy Ravinder Reddy (Managing Director), Vidya Sagar Reddy Donthri (Director). Past directors included Dontiri Vidya Sagar Reddy. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 2-3-97/3, Road No.3,Sai Nagar Colony Nagole, Hyderabad, Telangana, 500068.
U24239TG2004PLC044152
044152
13 September 2004
₹2.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ambit Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Regulapati Srinivas Rao | Director | 13 Sep 2004 | Current |
| Chittireddy Ravinder Reddy | Managing Director | 13 Sep 2004 | Current |
| Vidya Sagar Reddy Donthri | Director | 13 Sep 2004 | Current |
| Datla Venkatrama Raju | Director | 13 Sep 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ambit Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ambit Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2013 | Syndicate Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ambit Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ambit Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambit Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ambit Drugs Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Ambit Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
A charge with Syndicate Bank amounted to Rs. 1.00 M with Charge ID 10422511 was registered on 23 Apr 2013. was recorded as a recent event.
Progress on Regulapati Srinivas Rao was appointed as a Director was appointed as a Director on 13 Sep 2004 & has been associated with this company since 21 years 2 months . was documented.
Chittireddy Ravinder Reddy was appointed as a Managing Director was appointed as a Managing Director on 13 Sep 2004 & has been associated with this company since 21 years 2 months . was recorded as a recent event.
The activity Vidya Sagar Reddy Donthri was appointed as a Director was appointed as a Director on 13 Sep 2004 & has been associated with this company since 21 years 2 months . was completed.
The CIN of Ambit Drugs Limited is U24239TG2004PLC044152.
Ambit Drugs Limited is headquartered at 2-3-97/3, Road No.3,Sai Nagar Colony Nagole, Hyderabad, Telangana, 500068.
Ambit Drugs Limited was incorporated on 13 September 2004.
The current directors of Ambit Drugs Limited are
The primary industry of Ambit Drugs Limited is Chemicals.
Ambit Drugs Limited is unlisted.
The authorized capital of Ambit Drugs Limited is ₹2.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Ambit Drugs Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX